Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

Literaturverzeichnis
after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8
randomised controlled trial. Lancet Oncol 10, 1160-1170.
Hodgkin, T. (1832). On some morbid appearances of the absorbent glands and spleen. Medical Chirurgical
Transaction 17, 68-97.
Hodgson, D.C., Koh, E.S., Tran, T.H., Heydarian, M., Tsang, R., Pintilie, M., Xu, T., Huang, L., Sachs, R.K.,
and Brenner, D.J. (2007a). Individualized estimates of second cancer risks after contemporary radiation therapy
for Hodgkin lymphoma. Cancer 110, 2576-2586.
Hodgson, D.C., Pintilie, M., Gitterman, L., Dewitt, B., Buckley, C.A., Ahmed, S., Smith, K., Schwartz, A.,
Tsang, R.W., Crump, M., Wells, W., Sun, A., and Gospodarowicz, M.K. (2007b). Fertility among female
hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol 25, 11-15.
Hoppe, B.S., Flampouri, S., Su, Z., Morris, C.G., Latif, N., Dang, N.H., Lynch, J., Li, Z., and Mendenhall, N.P.
(2012). Consolidative Involved-Node Proton Therapy for Stage IA-IIIB Mediastinal Hodgkin Lymphoma:
Preliminary Dosimetric Outcomes From a Phase II Study. International Journal of Radiation
Oncology*Biology*Physics 83, 260-267.
Hoppe, R.T. (2008). Hodgkin Lymphoma. In Perez and Brady's principles and practice of radiation oncology,
E.C. Halperin, ed. (Philadelphia, Pa. [u.a.]: Wolters Kluwer, Lippincott Williams & Wilkins), pp. 1721-1738.
Hoppe, R.T. (2010). The NCCN Clinical Practice Guidelines in Oncology, Hodgkin Lymphoma, V.2.2010,
http://www.nccn.org. National Comprehensive Cancer Network. letzter Zugriff August 2010.
Horning, S.J., Hoppe, R.T., Breslin, S., Bartlett, N.L., Brown, B.W., and Rosenberg, S.A. (2002). Stanford V
and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical
trial. J Clin Oncol 20, 630-637.
Horning, S.J., Hoppe, R.T., Hancock, S.L., and Rosenberg, S.A. (1988). Vinblastine, bleomycin, and
methotrexate: an effective adjuvant in favorable Hodgkin's disease. J Clin Oncol 6, 1822-1831.
Hoskin, P.J., Lowry, L., Horwich, A., Jack, A., Mead, B., Hancock, B.W., Smith, P., Qian, W., Patrick, P.,
Popova, B., Pettitt, A., Cunningham, D., Pettengell, R., Sweetenham, J., Linch, D., and Johnson, P.W. (2009).
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's
Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. J
Clin Oncol 27, 5390-5396.
Hough, R.E., and Hancock, B.W. (2007). Principles of chemotherapy in Hodgkin Lymphoma. In Hodgkin
Lymphoma, R.T. Hoppe, P.M. Mauch, J.O. Armitage, V. Diehl, and L.M. Weiss, eds. (Philadelphia, USA:
Lippincott Williams & Wilkins), pp. 189-204.
Hudson, M.M., Krasin, M., Link, M.P., Donaldson, S.S., Billups, C., Merchant, T.E., Kun, L., Billet, A.L.,
Kaste, S., Tarbell, N.J., Howard, S., Friedmann, A.M., Hurwitz, C.A., Young, J.A., Marcus, K.C., Rai, S.,
Cowan, T., and Weinstein, H.J. (2004). Risk-adapted, combined-modality therapy with VAMP/COP and
response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 22, 4541-
4550.
Hurkmans, C.W., Cho, B.C., Damen, E., Zijp, L., and Mijnheer, B.J. (2002). Reduction of cardiac and lung
complication probabilities after breast irradiation using conformal radiotherapy with or without intensity
modulation. Radiother Oncol 62, 163-171.
Hutchings, M., Loft, A., Hansen, M., Pedersen, L.M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F.,
Boesen, A.M., Berthelsen, A.K., and Specht, L. (2006). FDG-PET after two cycles of chemotherapy predicts
treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107, 52-59.
Irvine, C., Morgan, A., Crellin, A., Nisbet, A., and Beange, I. (2004). The clinical implications of the collapsed
cone planning algorithm. Clin Oncol (R Coll Radiol) 16, 148-154.
Jackson, A., Kutcher, G.J., and Yorke, E.D. (1993). Probability of radiation-induced complications for normal
tissues with parallel architecture subject to non-uniform irradiation. Med Phys 20, 613-625.
Jacobs, C. (2010). Henry Kaplan and the story of Hodgkin's disease, 1. edn (Stanford, California: Stanford
University Press).
Jang, S.Y., Liu, H.H., and Mohan, R. (2008). Underestimation of Low-Dose Radiation in Treatment Planning of
Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys 71, 1537-1546.
Jang, S.Y., Liu, H.H., Wang, X., Vassiliev, O.N., Siebers, J.V., Dong, L., and Mohan, R. (2006). Dosimetric
verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo
approaches. Int J Radiat Oncol Biol Phys 66, 939-948.
128